The trademark application ELIHIB was filed by G.L. Pharma GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on July 24, 2024, and it was registered by office on October 31, 2024 without any oppositions.
The application was filed in German (English was selected as the second language).